Product Information

Rapid Home Test for Hepatitis B and C Virus

Home Bio Test Hepatitis B and Hepatitis C rapid test determines if antibodies to the hepatitis B or C virus exist in your body. This test is easy-to-use in your own home and guarantees complete confidentiality.

The Silent Killer, Hepatitis C is a growing public health concern. Home Bio Test gives you a way to obtain a confidential answer to the question of your own Hepatitis status.

Accuracy:
Home Bio Test rapid Hepatitis tests are greater than 99% accurate as demonstrated in multi-center clinical trials. They are the same tests used by doctors and hospitals.

Who Should Get Tested?
Anyone who may have been exposed to hepatitis C through a blood transfusion or organ transplant before 1992; anyone who has had occupational exposure including healthcare work or military service; anyone that may have been exposed through sexual contact with someone known to be hepatitis B or C positive; and anyone that may have taken non-prescribed drugs or steroids by needle. Over 4 million Americans are infected.

Why Get Tested?
Early detection is important in determining appropriate treatments. Anyone who is infected with hepatitis C should refrain from drinking alcohol to avoid further liver damage.

Be the first to review this product!

Price: $39.95 $34.95

* Tell a Friend
* Write review / comment

Hepatitis – Be Positive

Hepatitis B is a life-threatening liver disease caused by the Hepatitis B virus (HBV). According to WHO reports it is a major global health issue with two million people being infected with HBV and 360 million people being afflicted with long- term liver infections.


Hepatitis B is more prevalent in China, the Indian subcontinent and other parts of Asia. It is also prevalent in the Amazonian regions and parts of central and Eastern Europe. In affluent countries of the US and Europe the incidence of the infection has significantly reduced due to widespread HBV vaccination programs.

Hepatitis B is the most serious of all forms of hepatitis. Infection during childhood is always followed by a chronic condition during adulthood. The clinical spectrum associated with adult infection ranges from a self limiting acute stage with complete viral clearance (in the majority) to a symptom-free carrier state which can progress to a chronic state that puts the patients (5-10%) at a higher risk of developing cirrhosis or liver cancer.

Viral determinants and the immuno-competence of the patients have been implicated in the progression of the disease.

Modes of Transmission

HBV is a virus that is more potent than the HIV with a mode of transmission similar to the AIDS virus. It is transmitted by coming in contact with the infected person’s body fluids such as blood or semen. Some of the common methods of transmission include-

• Mother to baby (peri-natal)

• Childhood infections (interpersonal associations)

• Using infected injection needles

• Blood transfusions

Structure of the hepatitis B virus

(Acknowledgement: Baruch S. Blumberg)The identification of HBV led to the development of vaccines using HBsAg particles isolated from the serum of chronic carriers and later, after the genome of the HBV had been cloned, recombinant DNA vaccines.

HBV has been classified into eight genotypes, each with a distinct geographical and ethnic distribution:

Genotypes A and D - Africa, Europe and India
Genotypes B and C - Asia
Genotype E - West Africa
Genotype F - Central and South America
Genotype G - France, Germany and the USA
Genotype H - Central America

Hepatitis B presents clinical staff with many difficult challenges. Disease management is still developing, influenced by the introduction of new drugs and the evolution of new data. Treatment is complicated, may be costly and time consuming. While there is an effective vaccination for HBV, it is not universally available. Dealing with patient uncertainties about therapy and the social and occupational implications arising from this may present further problems.

This section reviews current understanding about hepatitis B and provides a framework for optimal management of the disease by health professionals.
Hep B virus

Hepatitis B Vaccine

Product Description

made with the new generation of recombinant gene technique is characterized by "Three Highness and One Extensive Coverage"


Higher antibody seroconversion rate
Higher antibody titer
Higher prevention rate in establishment of carrier state in infants
More extensive immunization coverage of people: suitable for all the susceptible ranging between 0~60 years of age
Company: Dalian Scicon Bio-Tech Co., Ltd.
Other products from this company

* Interferon Concentrated Liquid
* Recombinant Hirudin
* Interleukin-2 Concentrated Liquid
* Epidermal Growth Factor(EGF)

HIV and Hepatitis B or C

filed under: HIV hepatitis B C treatment BHIVA guidelines

BHIVA has written new guidelines for the management of co-infection with HIV and hepatitis B or C and want people's comments. These guidelines replace the existing separate guidelines for HIV and Hepatitis B, and HIV and Hepatitis C. You can make your comments at the BHIVA website


These 2009 guidelines incorporate all new relevant information since the previous versions in 2005.

For 2009 we have decided to amalgamate the two guides for hepatitis coinfection into a single document. This avoids duplication, because general treatment for chronic liver disease is similar for both.


The translation of study data into clinical practice is often difficult, even with the best possible evidence, because of differences in factors such as trial design and inclusion criteria. Recommendations based upon expert opinion have the weakest evidence but provide an important reason for writing the guidelines – to produce a consensual opinion about current practice. The Writing Group seeks to provide guidelines that optimize treatment and management, but this needs to be tailored to fit the person - the draft is not suggesting a fixed standard for all.



Changes
The major changes/amendments include:

* More discussion on hepatitis screening and prevention;
* Clarification on the role of liver biopsy and non-invasive liver fibrosis assessment;
* More emphasis on screening for delta virus;
* More discussion on end-stage liver disease management and HCC screening;
* Molecular diagnostic tests used for the diagnosis and management of Hepatitis B and Hepatitis C;
* Revised CD4-based guidance on the management of chronic Hepatitis B;
* Management of acute Hepatitis B;
* Revised guidance on the management of chronic HCV, including ART interactions;
* Management of acute Hepatitis C
* Management of treatment non-responders and relapsers in both chronic Hepatitis B and C.



The consultation deadline is 5 June

BHIVA consultation page

Managing Coinfection with HIV and Hep B and C download the pdf

Online feedback form

Hepatitis B, C Test

Hepatitis B and Hepatitis C Are Both Treatable and Curable in Many Cases. The Safest Thing To Do is To Take the Test.
$199.00

For only $199 dollars you'll receive a Confidential Hepatitis B and C Test at a National Laboratory in your area.

Call us at 1-800-456-9913 to set your test up at our std testing center. We have thousands of locations and one near you.

Viral Hepatitis is a group of disease that infect the liver. Three viruses - Hepatitis A, Hepatitis B and Hepatitis C are the most frequent viruses, and these are the viruses we test for.

Hepatitis A is a frequent virus of childhood and is not considered a deadly and serious infection. Vaccinations are available for Hepatitis A is you are going to third world country where hepatitis A is prevalent and you are not immune. .

Hepatitis B is an infectious viral disease transmitted by body fluids or needles. This panel can help determine if you are an infectious carrier of Hepatitis B, or if you have been exposed to Hepatitis B and are not infectious. Hepatitis B can cause severe acute infections and severe chronic infections. It is important to know your hepatitis B status because it is not rare and it can have serious long term effects that can be treated. Our Test for hepatitis B shows if you are immune, if you have been infected or are infectious.

If you have no reaction (Not immune) to Hepatitis B virus and have a lifestyle that exposes you to body fluids of other people, a vaccine can protect you. It is now a standard shot for children before they enter elementary school.

Hepatitis C is transmitted through blood routes, needles, tattoos and sexual activity. This test indicates if you have been exposed to Hepatitis C. Hepatitis C is a quiet virus that may not be noticed except for mildly elevated liver enzymes checked for by the health panel. This virus may slowly eat away at your liver causing scarring and damage and finally almost total liver destruction.

The good news about Hepatitis B and C is that these viruses are treatable and the infected person in many cases can be totally cured and rendered virus free. The hepatitis panel we offer for Hepatitis B and C is available for $199. It takes 3 to 6 months after exposure to develop hepatitis antibodies. Results usually return in 3 to 5 days.

Tattoos? Unsure of your exposure? Take Control.

Call 1-800-456-9913 to speak to one of our counselors to schedule your test today.
$199.00

Hepatitis B (HBV)

What is hepatitis B (HBV)?

Hepatitis B is a disease of the liver caused by the hepatitis B virus. Hepatitis B has a wide range of clinical presentations. It can be mild, without symptoms, or it may cause chronic hepatitis. In some cases, when infants and young children acquire hepatitis B, they are at high risk for chronic liver disease and liver failure. Transmission of hepatitis B virus occurs through blood and body fluid exposure such as blood, semen, vaginal secretions, or saliva. Infants may also develop the disease if they are born to a mother who has the virus. Infected children often spread the virus to other children if there is frequent contact (i.e., household contact) or a child has many scrapes or cuts. The following describes persons who are at risk for developing hepatitis B:

* children born to mothers who have hepatitis B
* children who are born to mothers who have immigrated from a country where hepatitis B is widespread such as southeast Asia and China
* children who live in long-term care facilities or who are disabled
* children who live in households where another member is infected with the virus
* children who have a blood clotting disorder such as hemophilia and require blood products
* children who require dialysis for kidney failure
* adolescents who may participate in high-risk activities such as IV drug use and/or unprotected heterosexual or homosexual contact

People can contract hepatitis B virus infection without knowing how they got it. About one-third of hepatitis B cases in the United States have an unknown source.
Why is hepatitis B a concern?

The younger the person, the greater the likelihood of staying infected with hepatitis B and having life-long liver problems, such as scarring of the liver and liver cancer.
Hepatitis B immunization:

A vaccine for Hepatitis B does exist and is now widely used for routine childhood immunization. Children currently receive the first vaccine between birth and 2 months, the second vaccine at 1 to 4 months and the third vaccine at 6 to 18 months. The vaccine is generally required for all children born on or after January 1, 1992, before they enter school. The vaccine is available for older children who may have not been immunized before 1992 and is recommended before age 11 or 12. Hepatitis B vaccine will prevent this disease. Three doses are needed for full and lasting immunity. Hepatitis B vaccine may be given at the same time as other vaccines.

* Infants of mothers that have hepatitis should receive hepatitis B immune globulin and the hepatitis B vaccine in the first 12 hours of birth.
* Infants of hepatitis B-negative mothers can receive the first dose up to 2 months of age.
* The second dose must be given at least one month after the first dose.
* The third dose must be given at least two months after the second dose and at least four months after the first. The third dose should not be given to infants younger than 6 months of age.
* Catch-up immunization may occur between 7 to 18 years of age.

What are the risks from hepatitis B vaccine?

A vaccine, like any medication, is capable of causing serious problems, such as severe allergic reactions. The risk of hepatitis B vaccine causing serious harm, or death, is extremely small. Persons who have a life-threatening allergy to baker's yeast should not receive the hepatitis B vaccine.

Receiving hepatitis B vaccine is much safer than contracting hepatitis B disease. Most people who receive hepatitis B vaccine do not have any problems with it. Risks may include:

* soreness in the location where the shot was given, lasting a day or two
* fever
* serious allergic reaction (very rare)

How do I care for my child after immunization with hepatitis B vaccine?

* Give your child an aspirin-free pain reliever, as directed by your child's physician.
* Watch for signs of reaction such as high fever, difficulty breathing, behavior change, fast heart rate, or dizziness. Report these or any other unusual signs immediately to your child's physician.

Introduction The hepatitis B virus

The hepatitis B virus is classified by the World Health Organisation (WHO) as the world’s second greatest carcinogen after tobacco.

Type B hepatitis is caused by the hepatitis B virus (HBV), a small enveloped DNA virus that infects the liver causing hepatocellular necrosis and inflammation. HBV can cause either an acute illness or chronic, persistent infection. Acute or chronic infection can lead to severe liver damage and is therefore potentially fatal.

After the identification in 1965 of the hepatitis B surface antigen, called HBsAg, hepatitis B was clearly linked to the development of cirrhosis and primary liver cancer. The virus and subviral particles were identified in serum and the genome of the virus was isolated and characterised as a small circular molecule of DNA.

General Information

General Information
Members of the Hepadnaviridae Family | Clinical Manifestations | Epidemiology | High Risk Populations | Transmission | Tropism | Cancer

Members of the Hepadnaviridae Family:

HEPADNAVIRIDAE family lineage

Orthohepadnavirus (mammals) genus

DHBV - Duck Hepatitis Virus (Ducks and Geese)

HHBV - Heron Hepatitis B virus

Others: Ross' Goose Hepatitis B virus, snow goose hepatitis B virus, and stork hepatitis B virus

Avihepadnavirus (avian) genus

HBV - Hepatitis B Virus (Humans and Chimps)

WHV - Woodchuck Hepatitis Virus (Woodchucks)

GSHV - Ground Squirrel Hepatitis Virus (Squirrels, woodchucks, chipmunks)

WMHV - Wooly Monkey Virus (Wooly Monkey)

Others: Old World and New World primate viruses

WHV and GSHV both are morphologically the same as HBV and have about 60% of the same sequence as HBV. HBV only grows in humans and chimps, but not baboons or lower animal species.

Clinical Manifestations: How do you know you have Hepatitis B?

30% of infected individuals do NOT have symptoms. Those who do present with jaundice, fatigue, abdominal pain, loss of appetite, nausea, vomitting, and joint pain. Fever can be absent or mild. After infection, the incubation period between exposure and first symptoms is 45-120 days, averaging around 60-90 days. This period is affected by the amount of virus in the inoculum, mode of transmission, and factors relating to the host. Primary infection is usually associated with little or no liver disease and mild to fulminant hepatitis.

The next phase of disease, icteric phase, usually occurs 10 days after symptoms begin. Dark urine followed by pale stools, yellowish coloring in the mucous membranes, conjunctivae, sclerae (whites of eyes), and skin then appear. Clinically, Jaundice is indicated by bilirubin levels of 20-40mg/L. It is accompanied by hepatomegaly and splenomegaly.

The infection usually resolves after 4-8 weeks. Most patients recover with few consequences and without recurrence in the future. Young children rarely are affected and develop disease; however those that are are at a high risk of becoming chronic carriers, especially if they are under the age of 7.

The hallmark of acute Hep B infection is a large increase in serum transaminase (aminotransferase) activity.
Epidemiology: Where is Hepatitis B found?

There are 350 million carriers of Hepatitis B worldwide and most of them are concentrated in developing countries. Hepatitis B is a disease of the poor. Sub-Saharan Africa, most of Asia, and the Pacific are hit hardest. The Amazon, southern parts of Eastern Europe, and Central Europe are also affected. In Western Europe and the United States, the prevalence is only 1%. It is estimated that there are 1.2 million carriers in the United States. Most of these individuals are infected during childhood and up to 10% of them become chronically infected. In these regions, liver cancer is one of the top 3 killers of adult males.

estimated that about 4 million people

It is estimated that about 4 million people in the United States are infected with hepatitis C, which is about 2% of the population. This makes hepatitis C much more common than HIV infection. There is an estimated 200 million people infected with HCV world wide.

And then there is Hepatitis B, a more readily transmitted virus which is rapidly becoming an monumental epidemic. Some facts bout Hepatitis B:

* 2 billion people have been infected with HCB (1 out of 3 people).
* 400 million people are chronically infected.
* 10-30 million will become infected each year.
* An estimated 1 million people die each year from hepatitis B and its complications.
* Approximately 2 people die each minute from hepatitis B.

Hepatitis C and B have been compared to a “viral time bomb”.

Apparently on the 19th May 2009 a few days prior the exact Jupiter Chiron Neptune conjunction the countries of the world celebrate “World Hepatitis Day”. Lets hope that the news is good and that the World Health Organisation announces research advancements in the fight against our many diseases and viral threats. God forbid that Swine Flu has any chance of advancing in the world.

The three major planetary bodies of Chiron, Jupiter and Neptune are highlighting the nature of our Global health. The conjunction is operating in “unseeable” or collective frameworks. One could say that our world is not in good shape presently. The stress from our global financial recession, our environmental issues and the threats of disease are major underlying themes that we cannot ignore in our lives. The question is how will we help reduce the stress in the face of our current realities? Society has tended to use drugs and alcohol and even take spiritual avenues to quell the stresses of too much reality. I cant see those options changing in the near future.

Chiron, Jupiter and Neptune are co joining to highlight our global health predicaments. The Cosmos usually throws something at us so that we sit up and take notice.

Our World is in a state of ill-health it seems – hopefully the Doctor is on his way?

Kingsley

PayTC.US

PayTC.US

From Wikipedia, the free encyclopedia
(Redirected from Bloodborne pathogen)
Jump to: navigation, search

A blood-borne disease is one that can be spread by contamination by blood.

The most common examples are HIV, hepatitis B, and hepatitis C.

Diseases that are not usually transmitted directly by blood contact, but rather by insect or other vector, are more usefully classified as vector-borne disease, even though the causative agent can be found in blood. Vector-borne diseases include West Nile virus and malaria.

Many blood-borne diseases can also be transmitted by other means.

Since it is difficult to determine what pathogens any given blood contains, and some blood-borne diseases are lethal, standard medical practice regards all blood (and any body fluid) as potentially infective. Blood and Body Fluid precautions are a type of infection control practice that seeks to minimize this sort of disease transmission.

Blood for blood transfusion is screened for many blood-borne diseases.
Retrieved from "http://en.wikipedia.org/wiki/Blood-borne_disease"

Category: Infectious diseases

These services are available for homeowners, apartments, business owners, property management companies, shopping malls, mass transportation services, health departments, school boards, colleges, local, state, and federal agencies in these cities Acworth, Adairsville, Adel, Albany, Alma, Alpharetta, Americus, Ashburn, Athens, Atlanta, Augusta, Austell, Bainbridge, Barnesville, Baxley, Blackshear, Blairsville, Blakely, Blue Ridge, Bogart, Bremen, Brunswick, Buford, Byron, Cairo, Calhoun, Camilla, Canton, Carrollton, Cartersville, Cedartown, Chatsworth, Chickamauga, Clarkesville, Clarkston, Claxton, Clayton, Cleveland, Cochran, Colquitt, Columbus, Commerce, Conyers, Cordele, Cornelia, Covington, Cumming, Dacula, Dahlonega, Dallas, Dalton, Darien, Dawson, Dawsonville, Decatur, Donalsonville, Douglas, Douglasville, Dublin, Duluth, Eastman, Eatonton, Elberton, Ellijay, Evans, Fairburn, Fayetteville, Fitzgerald, Flowery Branch, Forest Park, Forsyth, Fort Oglethorpe, Fort Valley, Gainesville, Glennville, Gray, Greensboro, Griffin, Grovetown, Hampton, Hartwell, Hawkinsville, Hazlehurst, Helen, Hephzibah, Hiawassee, Hinesville, Hiram, Jackson, Jasper, Jefferson, Jesup, Jonesboro, Kennesaw, Kingsland, La Fayette, Lagrange, Lake Park, Lavonia, Lawrenceville, Leesburg, Lilburn, Lincolnton, Lithia Springs, Lithonia, Loganville, Lyons, Mableton, Mac On, Madison, Marietta, Mc Rae, McDonough, Metter, Milledgeville, Monroe, Montezuma, Morrow, Moultrie, Nashville, Newnan, Norcross, Peachtree City, Perry, Pooler, Powder Springs ,Quitman, Richmond Hill, Rincon, Ringgold, Riverdale, Rockmart, Rome, Rossville, Roswell, Royston, Saint Marys, Saint Simons Island, Sandersville, Savannah, Smyrna, Snellville, Springfield, Statesboro, Stockbridge, Stone Mountain, Summerville, Suwanee, Swainsboro, Sylvania, Sylvester, Thomaston, Thomasville, Thomson, Tifton, Toccoa, Trenton, Tucker, Union City, Valdosta, Vidalia, Vienna, Villa Rica, Warner Robins, Washington, Watkinsville, Waycross, Waynesboro, West Point, Winder, Woodstock, Georgia.

A Hepatitis-Diabetes

A Hepatitis-Diabetes Connection?

It may be hepatitis coinfiection -- and not anti-HIV medications -- that is putting you at risk for diabetes, researchers say.
Researchers examining the possibility of a link between HIV infection and the risk of developing Type 2 diabetes instead found that another common coinfection might be behind the high rates of diabetes among HIVers: hepatitis C. An analysis of more than 6,400 patients at Veterans Affairs hospitals has shown that HIV-HCV coinfection was a strong predictor of increased diabetes risk. Hepatitis or HIV infections alone were not. Other factors associated with increased diabetes risks included being male, being nonwhite, having a high body mass index, and using nucleoside analog or nonnuke medications.